Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120099) titled 'Clinical Study of 3+T&E Regimen for Neovascular Age-Related Macular Degeneration (nAMD) Under Different Trial Criteria' on March 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Huai'an First People's Hospital
Condition:
Age-related macular degeneration (AMD)
Intervention:
HAWK/HARRIER Group :Intravitreal injection of 0.05ml of Conbercept eye injection under the 3+T&E regimen of the HAWK/HARRIER trial standards.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-10
Target Sample Size: HAWK/HARRIER Group :30;PULSAR Group :30;
Countries of Rec...